Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC

Thursday,  January 19, 2023

10:00AM – 11:00AM ET

Please note this TeleECHO program is 10:00AM Eastern, 9:00AM Central, 8:00AM Mountain and 7:00AM Pacific.

PROGRAM OVERVIEW

This live virtual activity provides an opportunity for community oncologists and advanced practice providers to interact with experts to quickly get up to speed on the latest advances in EGFR-mutated NSCLC. During this program, faculty will describe the prognostic and predictive roles of common EGFR-mutations and the high risk clinical and disease characteristics to be aware of in patients with NSCLC. Through a review of clinical trial data and recent guidelines updates, faculty will increase confidence in individualizing treatment that addresses the underlying molecular pathology of disease. Participants will be encouraged to share their own cases and engage with faculty throughout this activity. Innovative learning platforms and practice tools will reinforce incorporation of targeted treatments into practice to help improve outcomes for patients with EGFR-mutated NSCLC.

PRESENTING FACULTY
Mark A. Socinski, MD
Executive Medical Director
AdventHealthCancer Institute
Orlando, FL

TARGET AUDIENCE

This activity is designed to meet the educational needs of global oncologists and other community-based healthcare practitioners who care for patients with lung cancer.

LEARNING OBJECTIVES

Upon the completion of this program, attendees should be able to:

  • Describe the various molecular diagnostics of EGFR-mutated NSCLC and associated subtypes
  • Assess the association between EGFR-mutated NSCLC subtypes with clinical presentation and outcomes
  • Apply key genomic findings, including high risk markers in the choice of combination therapy in patients with EGFR-mutated, metastatic NSCLC to optimize outcomes

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with lung cancer.

CNE Credit: 1.0 ANCC Contact Hour.

CNE ACCREDITATION STATEMENT

Ultimate Medical Academy/CCM is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 1.0 contact hours of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at http://www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.